We are live on
!
Find out more
EFG
Everhart Financial Group Portfolio holdings
AUM
$1.56B
1-Year Est. Return
34.29%
This Fund
S&P 500
This Quarter
Est. Return
+21.04%
1 Year Est. Return
+34.29%
3 Year Est. Return
+113.3%
5 Year Est. Return
+134.07%
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
+$389M
(+33%)
Cap. Flow
+$201M
Cap. Flow
% of AUM
12.84%
Top 10 Holdings %
Top 10 Hldgs %
54.31%
Holding
517
New
53
Increased
154
Reduced
254
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
|
+$53.4M |
| 2 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$49.6M |
| 3 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$49.6M |
| 4 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$46.3M |
| 5 |
Apple
AAPL
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.29M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$3.55M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.96M |
| 4 |
iShares Select Dividend ETF
DVY
|
+$2.2M |
| 5 |
NVIDIA
NVDA
|
+$2.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 60.05% |
| 2 | Technology | 16.02% |
| 3 | Financials | 4.57% |
| 4 | Industrials | 3.77% |
| 5 | Healthcare | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Novartis
NVS
$304B
| $208K | 0.01% |
1,326
+5
| +0.4% | +$750 |
|
452
International Flavors & Fragrances
IFF
$22B
| $208K | 0.01% |
+2,623
| New | +$195K |
|
453
FormFactor
FORM
$8.12B
| $207K | 0.01% |
+1,292
| New | +$171K |
|
454
Monster Beverage
MNST
$85.8B
| $205K | 0.01% |
+4,270
| New | +$179K |
|
455
Banco Santander
SAN
$217B
| $204K | 0.01% |
14,778
-99
| -0.7% | -$1.23K |
|
456
Accenture
ACN
$114B
| $204K | 0.01% |
1,637
-164
| -9% | -$28.5K |
|
457
Nutanix
NTNX
$18.4B
| $202K | 0.01% |
+3,967
| New | +$179K |
|
458
United Airlines
UAL
$36.2B
| $202K | 0.01% |
+1,486
| New | +$154K |
|
459
Zoetis
ZTS
$31.3B
| $202K | 0.01% |
+2,811
| New | +$265K |
|
460
Semtech
SMTC
$13.8B
| $202K | 0.01% |
+1,247
| New | +$163K |
|
461
Baker Hughes
BKR
$63B
| $201K | 0.01% |
3,630
-39
| -1% | -$2.47K |
|
462
Avantis Emerging Markets Equity ETF
AVEM
$28.7B
| $201K | 0.01% |
+2,085
| New | +$192K |
|
463
Lennar Class B
LEN.B
$19.8B
| $200K | 0.01% |
+2,256
| New | +$197K |
|
464
Wendy's
WEN
$1.53B
| $174K | 0.01% |
20,953
-42
| -0.2% | -$300 |
|
465
Cushman & Wakefield Ltd
CWK
$3.21B
| $173K | 0.01% |
12,891
| – | – |
|
466
Neogen
NEOG
$2.58B
| $162K | 0.01% |
18,058
| – | – |
|
467
Blue Owl Capital
OBDC
$5.62B
| $136K | 0.01% |
+12,477
| New | +$140K |
|
|
ONCY
468
Oncolytics Biotech
ONCY
$108M
| $134K | 0.01% |
140,899
+2,738
| +2% | +$2.54K |
|
469
Alpha Tau Medical
DRTS
$1.39B
| $126K | 0.01% |
+10,000
| New | +$90.8K |
|
|
CNH
470
CNH Industrial
CNH
$23.2B
| $118K | 0.01% |
+10,515
| New | +$112K |
|
471
Immix Biopharma
IMMX
$990M
| $103K | 0.01% |
+10,000
| New | +$92.8K |
|
472
Lloyds Banking Group
LYG
$88B
| $67K | ﹤0.01% |
11,499
+434
| +4% | +$2.35K |
|
473
Clover Health Investments
CLOV
$2.26B
| $65.7K | ﹤0.01% |
12,546
| – | – |
|
|
DCH
474
Dauch Corp
DCH
$1.66B
| $65.1K | ﹤0.01% |
12,015
| – | – |
|
475
Cytek Biosciences
CTKB
$611M
| $57.4K | ﹤0.01% |
12,962
| – | – |
|
Similar funds
SCA
DAM
YIA
MSFS
PEGL
HRES
AIM
IEFM
Everhart Financial Group's Q2 2026 Portfolio in Review
As of Q2 2026, Everhart Financial Group held 517 positions worth $1.56B, up 33% from $1.17B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Everhart Financial Group deployed $201M of net new capital in Q2 2026, opening 53 new positions and adding to 154 existing holdings. Its largest new stake was Schwab Short-Term US Treasury ETF: 60,549 shares worth $1.46M.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 54% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.29M trimmed.
- Everhart Financial Group's largest Q2 2026 buy was Schwab Short-Term US Treasury ETF: 60,549 shares worth $1.46M.
- Everhart Financial Group added most to State Street SPDR S&P 600 Small Cap Growth ETF in Q2 2026, an estimated $53.4M increase.
- Everhart Financial Group's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.29M.
- Everhart Financial Group fully exited iShares Russell 1000 Value ETF in Q2 2026, selling an estimated $3.55M.
- Everhart Financial Group's ten largest holdings make up 54% of its $1.56B portfolio in Q2 2026.
- Everhart Financial Group opened 53 new positions and closed 36 in Q2 2026.
- Everhart Financial Group's portfolio value rose 33% quarter-over-quarter to $1.56B.
Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.